Prevalence and risk factors with type 2 diabetes mellitus among young adults at a district hospital in Trujillo, Peru
DOI:
https://doi.org/10.64716/8se17h52Palabras clave:
Diabetes Mellitus, Type 2, Young Adult, Prevalence, Risk Factors, Cross-Sectional StudiesResumen
Introduction: Type 2 diabetes mellitus (T2DM) can occur early in adulthood and coexist with metabolic abnormalities that increase the burden of disease in this population. Objective: To determine the prevalence of T2DM and the risk factors associated with the disease among young adults treated at a district hospital in Trujillo, Peru, between 2020 and 2024. Methods: An observational, retrospective, analytical, cross-sectional study was conducted among adults aged 18 to 30 years. Prevalence was estimated from 1,258 clinical records, while the analysis of risk factors was performed using 98 medical records. Age, sex, dyslipidemia, obesity, hypertension, and family history of T2DM were evaluated. Associations were assessed using the chi-square test and odds ratios, with a significance level of p < 0.05. Results: The prevalence of T2DM was 3% (39/1,258). In the analysis of 98 medical records, dyslipidemia (OR = 3.50; p = 0.012), obesity (OR = 3.80; p = 0.006), hypertension (OR = 3.45; p = 0.039), and family history of T2DM (OR = 3.33; p = 0.023) were significantly associated with T2DM. No significant associations were observed with age (p = 0.17) or sex (OR = 1.09; p = 0.85). Conclusions: Among the young adults studied, the prevalence of T2DM was 3%. Dyslipidemia, obesity, hypertension, and family history were identified as statistically significant risk factors associated with T2DM.
Descargas
Referencias
Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149-156. https://doi.org/10.1016/S2213-8587(25)00299-2 DOI: https://doi.org/10.1016/S2213-8587(25)00299-2
Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou SA. Early onset type 2 diabetes mellitus: an update. Endocrine. 2024;85(3):965-978. https://doi.org/10.1007/s12020-024-03772-w DOI: https://doi.org/10.1007/s12020-024-03772-w
Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Young-onset type 2 diabetes mellitus: implications for morbidity and mortality. Nat Rev Endocrinol. 2020;16(6):321-331. https://doi.org/10.1038/s41574-020-0334-z DOI: https://doi.org/10.1038/s41574-020-0334-z
Xu L, Ran J, Shao H, Chen M, Tang H, Li Y, et al. Incidence and risk factors of diagnosed young-adult-onset type 2 diabetes in the U.S.: the National Health Interview Survey 2016-2022. Diabetes Care. 2025;48(3):371-380. https://doi.org/10.2337/dc24-1699 DOI: https://doi.org/10.2337/dc24-1699
Ccorahua-Ríos MS, Atamari-Anahui N, Miranda-Abarca I, Campero-Espinoza AB, Rondón-Abuhadba EA, Pereira-Victorio CJ. Prevalencia de la diabetes mellitus tipo 2 en población menor de 30 años para el período de 2005 a 2018 con datos del Ministerio de Salud de Perú. Medwave. 2019;19(10):e7723. https://doi.org/10.5867/medwave.2019.10.7723 DOI: https://doi.org/10.5867/medwave.2019.10.7723
Carrillo-Larco RM, Bernabé-Ortiz A. Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general. Rev Peru Med Exp Salud Publica. 2019;36(1):26-36. https://doi.org/10.17843/rpmesp.2019.361.4027 DOI: https://doi.org/10.17843/rpmesp.2019.361.4027
Miravet-Jiménez S, Pérez-Unanua MP, Alonso-Fernández M, Escobar-Lavado FJ, González-Mohino Loro B, Piera-Carbonell A. Manejo de la diabetes mellitus tipo 2 en adolescentes y adultos jóvenes en atención primaria. Semergen. 2020;46(6):415-424. https://doi.org/10.1016/j.semerg.2019.11.008 DOI: https://doi.org/10.1016/j.semerg.2019.11.008
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https://doi.org/10.1371/journal.pmed.0040296 DOI: https://doi.org/10.1371/journal.pmed.0040296
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-126. https://doi.org/10.4103/0253-7176.116232 DOI: https://doi.org/10.4103/0253-7176.116232
American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27-S49. https://doi.org/10.2337/dc26-S002 DOI: https://doi.org/10.2337/dc26-S002
World Health Organization. Obesity and overweight. Geneva: World Health Organization; 2025. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
World Health Organization. Hypertension. Geneva: World Health Organization; 2025. https://www.who.int/news-room/fact-sheets/detail/hypertension
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants. JAMA. 2025;333(1):71-74. https://doi.org/10.1001/jama.2024.21972 DOI: https://doi.org/10.1001/jama.2024.21972
World Medical Association. WMA Declaration of Taipei on ethical considerations regarding health databases and biobanks. Ferney-Voltaire: World Medical Association; 2016. https://www.wma.net/policies-post/wma-declaration-of-taipei-on-ethical-considerations-regarding-health-databases-and-biobanks/
Tanoey J, Becher H. Diabetes prevalence and risk factors of early-onset adult diabetes: results from the Indonesian Family Life Survey. Glob Health Action. 2021;14(1):2001144. https://doi.org/10.1080/16549716.2021.2001144 DOI: https://doi.org/10.1080/16549716.2021.2001144
Reji S, Sankaraeswaran M, Ulagamathesan V, Wesley H, Ramesh G, Srinivasan S, et al. Cohort prevalence of young-onset type 2 diabetes in South Asia: a systematic review. Diabetes Res Clin Pract. 2025;221:112013. https://doi.org/10.1016/j.diabres.2025.112013 DOI: https://doi.org/10.1016/j.diabres.2025.112013
Nanditha A, Susairaj P, Satheesh K, Raghavan A, Snehalatha C, Ramachandran A. The rising prevalence of type 2 diabetes among the youth in southern India—an ancillary analysis of the Secular TRends in DiabEtes in India (STRiDE-I) study. J Diabetes. 2024;16(7):e13576. https://doi.org/10.1111/1753-0407.13576 DOI: https://doi.org/10.1111/1753-0407.13576
Tian X, Chen S, Zhang Y, Xu Q, Xia X, Wu S, et al. Age-specific effect and pathways of risk factors on the risk of incident type 2 diabetes: a 13-year prospective cohort study. Diabetes Metab Res Rev. 2025;41(1):e70028. https://doi.org/10.1002/dmrr.70028 DOI: https://doi.org/10.1002/dmrr.70028
Belete GK, Sithole HL. Prevalence and associated factors of diabetes among adult populations of Hawassa town, southern Ethiopia: a community based cross-sectional study. PLoS One. 2025;20(1):e0318081. https://doi.org/10.1371/journal.pone.0318081 DOI: https://doi.org/10.1371/journal.pone.0318081
Smith KR, Meeks H, Curtis D, Brown BB, Kole K, Kowaleski-Jones L. Family history of type 2 diabetes and the risk of type 2 diabetes among young and middle-aged adults. Chronic Dis Transl Med. 2025;11(1):46-56. https://doi.org/10.1002/cdt3.147 DOI: https://doi.org/10.1002/cdt3.147
Sattar N, Kennon B, White AD. Increased prevalence of younger onset type 2 diabetes: why and what could be done? Lancet Diabetes Endocrinol. 2024;12(10):687-690. https://doi.org/10.1016/S2213-8587(24)00231-6 DOI: https://doi.org/10.1016/S2213-8587(24)00231-6
Descargas
Declaración de disponibilidad de datos
The data supporting the findings of this study are not publicly available because of ethical and confidentiality restrictions associated with information obtained from medical records. Requests for access may be directed to the corresponding author and will be subject to the appropriate institutional authorization.
Número
Sección
Licencia
Derechos de autor 2026 Gandij Yamil Melendez-Medina (Autor/a)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores conservan los derechos de autor y conceden a TUMI Health Sciences Research el derecho de primera publicación. Los artículos se publican bajo la Licencia Internacional Creative Commons Atribución 4.0 (CC BY 4.0).
